Related Experiment Video
Updated: May 27, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
Network toxicology and molecular simulation identify key genes and pathways in PFAS-induced premature ovarian
Jiyu Che1, Yanyan Qu1, Weiran Liu2
1Endocrine and Metabolic Diseases Hospital of Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, 18877, Jingshi Rd, Jinan 250062, China; Jinan Key Laboratory of Translational Medicine on Metabolic Diseases, 18877, Jingshi Rd, Jinan 250062, China; Shandong Institute of Endocrine and Metabolic Diseases, Shandong First Medical University & Shandong Academy of Medical Sciences, 18877, Jingshi Rd, Jinan 250062, China.
Abstract:
Premature ovarian insufficiency (POI) is a reproductive disorder characterized by the early loss of ovarian function in women under 40 years of age. PFAS, especially PFOA and PFOS, have been implicated in ovarian dysfunction, but their mechanisms of action remain unclear. In this study, an integrative network toxicology approach was applied, combining target prediction, gene enrichment analysis, machine learning based feature selection, molecular docking, and molecular dynamics simulations, with transcriptomic validation using the GSE127453 dataset. 83 overlapping targets between PFAS and POI were identified. GO enrichment analysis indicated significant involvement in nuclear receptor mediated transcriptional regulation, including steroid hormone receptor and estrogen receptor signalin, KEGG analysis highlighted pathways related to progesterone-mediated oocyte maturation, cellular senescence, and the FoxO signaling pathway, implying dual toxicological mechanisms involving impaired oocyte development and accelerated ovarian cell aging. Eight core genes were identified, including SHBG, CDC25A, TPO, BMP2, MAPK1, CASP3, CDK2, and ESR1. Among them, BMP2, CDK2, SHBG, and TPO were downregulated, while CASP3 and ESR1 were upregulated in POI samples. Molecular docking and dynamics simulations revealed stable, high affinity interactions between PFAS and CASP3, supporting a potential role in apoptosis activation. Nonetheless, further in vitro, in vivo, and mixture-based studies are warranted to substantiate these computational predictions and clarify dose-response relationships.
Insights
Per- and polyfluoroalkyl substances (PFAS) may contribute to premature ovarian insufficiency (POI) by disrupting hormone regulation and accelerating ovarian cell aging. Computational models suggest PFAS interact with key genes like CASP3, potentially activating apoptosis.
Area of Science:
- Reproductive Toxicology
- Environmental Health
- Computational Biology
Background:
- Premature ovarian insufficiency (POI) affects women under 40, with unknown environmental causes.
- Per- and polyfluoroalkyl substances (PFAS) are linked to ovarian dysfunction, but mechanisms are unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms linking PFAS exposure to POI using an integrative network toxicology approach.
- To identify key genes and pathways affected by PFAS in the context of POI.
Main Methods:
- Integrative network toxicology: target prediction, gene enrichment (GO, KEGG), machine learning, molecular docking, and molecular dynamics simulations.
- Transcriptomic data validation (GSE127453 dataset).
Main Results:
- Identified 83 overlapping targets between PFAS and POI.
- Found significant involvement in nuclear receptor signaling, oocyte maturation, cellular senescence, and FoxO signaling pathways.
- Eight core genes identified; BMP2, CDK2, SHBG, TPO downregulated; CASP3, ESR1 upregulated in POI samples.
- Molecular simulations showed stable interactions between PFAS and CASP3, suggesting apoptosis activation.
Conclusions:
- PFAS may cause POI through dual mechanisms: impaired oocyte development and accelerated ovarian cell aging.
- CASP3 interaction suggests a role for PFAS in inducing apoptosis in ovarian cells.
- Further in vitro, in vivo, and mixture studies are needed to confirm findings and establish dose-response relationships.

